Surveillance for dysplasia is necessary for patients with ulcerative colitis. CON: Surveillance for ulcerative colitis-associated cancer: Time to change the endoscopy and the microscopy

Fergus Shanahan, Rodrigo Quera

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

9 Citas (Scopus)

Resumen

Expenditure of finite health-care resources on practices that have unproven or dubious efficacy needs careful reconsideration. The influence of medicolegal considerations on this aspect of patient management is a reality that needs to be addressed. While improvements in endoscopic techniques such as chromoendoscopy are encouraging, conventional histologic analysis of biopsy samples is suboptimal. One approach-perhaps idealistic-would be to direct resources toward fundamental research and development of better molecular biomarkers of increased risk of colitis-associated cancer. In the meantime, we may have to rely on increased efforts at primary prevention and common sense.

Idioma originalInglés
Páginas (desde-hasta)1633-1636
Número de páginas4
PublicaciónAmerican Journal of Gastroenterology
Volumen99
N.º9
DOI
EstadoPublicada - sept. 2004
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Surveillance for dysplasia is necessary for patients with ulcerative colitis. CON: Surveillance for ulcerative colitis-associated cancer: Time to change the endoscopy and the microscopy'. En conjunto forman una huella única.

Citar esto